A California company has created a first-of-its-kind eyedrop that corrects a certain type of vision impairment and could ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness. This regulatory milestone ...

Reading glasses might be the next thing to go the way of the flip phone. The FDA just approved VIZZ, a once-daily eye drop that helps you see up close without glasses. That’s a big deal if you’re over ...

The US FDA approval of Vizz was based on results from three randomised, double-masked, controlled Phase 3 studies.

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

Conference call and webcast to be held August 1, 2025 at 8:00 a.m. EDT ...